Heart TransplantationGraft RejectionImmunosuppressive AgentsCyclosporineKidney TransplantationTransplantation, HomologousPostoperative ComplicationsTime FactorsHeartRetrospective StudiesTacrolimusTransplantationGraft SurvivalHeart RateLung TransplantationTissue DonorsMycophenolic AcidOrgan TransplantationLiver TransplantationHeart FailureTreatment OutcomeCytomegalovirus InfectionsImmunosuppressionTransplantsTransplantation, HeterotopicHeart-Lung TransplantationWaiting ListsImmunocompromised HostHeart DiseasesHeart-Assist DevicesFollow-Up StudiesBiopsyTransplantation ImmunologyCyclosporinsRisk FactorsProspective StudiesBone Marrow TransplantationPostoperative PeriodTissue and Organ ProcurementBK VirusCytomegalovirusCardiomyopathy, DilatedSirolimusPolyomavirus InfectionsHistocompatibility TestingHeart Defects, CongenitalGanciclovirAzathioprineIsoantibodiesKidney Failure, ChronicLymphoproliferative DisordersMyocardiumCreatinineKidneyHeart, ArtificialDrug MonitoringIncidenceBronchiolitis ObliteransOpportunistic InfectionsSurvival RateLiving DonorsTablets, Enteric-CoatedTransplantation ToleranceBiological MarkersLiver FailureSurvival AnalysisDrug Therapy, CombinationAcute DiseaseCalcineurinGingival OvergrowthKaplan-Meier EstimateCohort StudiesRisk AssessmentAntilymphocyte SerumPrognosisHematopoietic Stem Cell TransplantationAntiviral AgentsHLA AntigensHemodynamicsKidney DiseasesCoronary DiseasePostoperative CarePancreas TransplantationHistocompatibilityRecurrenceFetal HeartCase-Control StudiesCardiomyopathiesChronic DiseaseCod Liver OilPredictive Value of TestsExercise TestWater-Electrolyte ImbalanceVentricular Function, LeftDrug SubstitutionProportional Hazards ModelsFatal OutcomeHeart ValvesCardiac CatheterizationEchocardiography